New Group Promotes AI, Robotics, and Automation in Healthcare
Goal Is to Improve Patient Access to Quality Care
Supplement: Cancer Immunotherapies Development Barriers
Current State of Protocol Design Impacting Small to Mid-Sized Biotech Companies
True CRISPR: A Genetic Genre with Novel Twists
With Multiplexing, Nanodelivery, and Other Advances, CRISPR Reality Outstrips CRISPR Fiction
Discovering the Fourth Paradigm in Data Standardization
Practical Method for Managing Modern Scientific Information
For full access to this article login to GEN Select now.
Timing Is Everything in Protein Formulation
Choosing When and How to Proceed Depends on Available Resources and Competition
- Formulation can make or break a development-stage protein drug, and add years of IP protection and value for post-patent molecules. Yet significant disagreement exists on the best time to undertake the formulation investment. Robert E. Zoubek, Ph.D., head of protein characterization and preformulation at Formycon, a business unit ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.